 |
TREATMENT GUIDELINES
The majority (90% to 98%) of sinus infections are caused by viruses and should not be treated with antibiotics, according to new guidelines from the Infectious Diseases Society of America. » More |
Editor's Pick
Racial/ethnic disparities exist in the diagnosis, treatment of depression
Minorities are less likely to receive a depression diagnosis and be treated for it than non-Hispanic Whites, according to a new study published online and ahead-of-print on December 15, 2011, in the American Journal of Public Health. » Click here. |
CONTINUING EDUCATION
Of the 35 new molecular entities approved by FDA in 2011, 17 are considered groundbreaking because of their potential to make a real difference in the lives of patients.
To read and print the article with TEST QUESTIONS, click here. To proceed to the online exams and earn up to 2 CPE credits, click here to login. |
CLINICAL NEWS
Rivaroxaban, an oral blood thinner, is equally effective as standard therapy for the treatment of pulmonary embolism and may cause fewer bleeding complications, according to new data. » More |
The blood-pressure medication prazosin was found to be an effective treatment to curb nightmares related to post-traumatic stress disorder, according to a poster presentation at the 20th European Congress of Psychiatry in Prague. » More |
Switching patients with rheumatoid arthritis to rituximab (Rituxan, Genentech) may be more effective than switching them to a second alternative anti-tumor necrosis factor (anti-TNF) after a first anti-TNF therapy has failed, according to a study published online in Arthritis Care & Research. » More |
The risk of Clostridium difficile infection among households is too low to justify interventions, other than avoiding unnecessary antimicrobials, according to a new study published in April’s Journal of Infection. » More |
Survey
a) Aging US population
b) Expanded coverage via HC reform
c) Price inflation by drug manufacturers
d) Growth in the specialty drug market
e) Increased incidence of key chronic diseases (eg, diabetes, CAD, asthma/COPD, etc.)
Click here and see what your colleagues think, too.
Want to see the results of our last survey regarding Medicare's coverage policy of immunosuppressive therapy following kidney transplantation? Click here. |
|
Digital Edition |
|
|
|
You are subscribed to %%list.name%% as %%emailaddr%%. Click here to unsubscribe or edit your member profile.
To ensure delivery to your inbox, please add us to your address book. If you need help doing this, Click here.
Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact information available to third parties for marketing purposes, simply call (toll free) 866-529-2922 at any time, or
fax us at 218-740-6417. Outside the U.S., please phone 218-740-6395. Contact us by mail at Advanstar Communications Inc., 131 West First St., Duluth, MN 55802-2065, USA.
|
|
|